Search clinical trials for: Viral Resistance

Total 30937 results

Ain Shams University

Completed

Resistance to Lamivudine in HBV Egyptian Patients

Chronic Hepatitis B Virus Treatment

Egypt
Yale University

Completed

The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment

HIV Infections | Opioid Dependence | HIV Positive | Opioid Agonist Treatment

United States
Johane Allard
Canadian Foundation for AIDS Research (CANFAR)

Completed

To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

HIV Infections

Canada
Hospitales Universitarios Virgen del Rocío

Completed

Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy (MonDar)

HIV-infection

Spain
Stanford University
University of California, Davis; Santa Clara Valley Health & Hospital System

Completed

The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens

HIV Infections

United States
Scott Palmer
Roche Pharma AG

Completed

Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation (Valgan)

Cytomegalovirus Infections

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People (FASTER)

HIV Infections

Peru, Brazil, South Africa
AbbVie (prior sponsor, Abbott)

Completed

A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies

Hepatitis C Virus Infection

United States
Korea University

Unknown

Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study (TeSLA)

Chronic Hepatitis B

Korea, Republic of
AbbVie (prior sponsor, Abbott)

Completed

Kaletra: Therapy With Double Protease Inhibitors

Human Immunodeficiency Virus

Germany
Cytheris SA

Completed

Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1) (ECLIPSE 1)

Hepatitis C

France, Switzerland, Italy
Cytheris SA

Unknown

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone (Eclipse 2)

Hepatitis C

France, Switzerland, Italy
Cytheris SA

Unknown

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy (ECLIPSE 3)

Hepatitis C

Taiwan
Medical Research Council
NHS Health Technology Assessment Programme

Unknown

Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT) (PIVOT)

Acquired Immunodeficiency Syndrome | HIV Infection
Pharmahungary Group
Hoffmann-La Roche

Completed

Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation

Influenza

Hungary
Harvard School of Public Health (HSPH)
Bristol-Myers Squibb; McGill University Health Centre/Research Institute of... and other collaborators

Completed

The Adult Antiretroviral Treatment and Resistance Study (Tshepo)

HIV Infection | AIDS

Botswana
Kaohsiung Veterans General Hospital.

Unknown

Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance

Insulin Resistance | Chronic Hepatitis c

Taiwan
St Stephens Aids Trust

Unknown

Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma (SSAT042)

Lymphoma | HIV

United Kingdom
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Pilot Study of Metabolic Syndromes and HIV Infections in Indian Tibetans

HIV Infection | Metabolic Syndromes

Taiwan
Hoffmann-La Roche

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Hepatitis C, Chronic

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Vanderbilt University School of Medicine

Completed

HIV Resistance and Treatment Strategies

HIV Infections

United States
Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline; Hoffmann-La Roche

Terminated

Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir (BIVIR)

Gastric Influenza

France
Brooke Army Medical Center
InterMune

Completed

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

Hepatitis C

United States
Yonsei University

Unknown

Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of
Avexa

Terminated

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

HIV Infections

Canada, United States, Australia, United Kingdom, Thailand, Germany, Italy, Israel, Belgium, Puerto Rico, Peru
University of Sydney

Completed

The Effect of a Nutritional Supplement in Individuals With Type 2 Diabetes Mellitus: a Pilot Study

Diabetes Mellitus, Type 2 | Insulin Resistance

Australia
Institut de Recherche pour le Developpement
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

HIV Infections

Thailand
Institut de Recherche pour le Developpement

Completed

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

HIV Infections

Thailand
Abbott
Lincoln Medical and Mental Health Center; Readitwell

Completed

Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs) (EOLE)

HIV Infection

France
French National Agency for Research on AIDS and...
Gilead Sciences; European and Developing Countries Clinical Trials Partnership...

Completed

Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA) (TEmAA)

HIV Infection | Pregnancy

Cambodia, South Africa, Côte D'Ivoire
Gilead Sciences

Completed

CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study (CHARM)

Chronic Hepatitis B

Australia
University Health Network, Toronto

Completed

Lifestyle Intervention Targetting Obesity and Insulin Resistance in Chronic Hepatitis C

Obesity | Hepatitis C | Metabolic Syndrome | Insulin Resistance

Canada
Karolinska Institutet
Hanoi Medical University

Unknown

Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure (DotArv)

Human Immunodeficiency Virus (HIV)

Vietnam
Abbott

Completed

Evaluation of Kaletra Therapy Over the Long-term

Human Immunodeficiency Virus

Germany
Novartis

Terminated

Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone

Hepatitis B

Korea, Republic of, Thailand, United States, Hong Kong, Taiwan
Avexa

Withdrawn

A Long Term Safety Study of Apricitabine in HIV-infected Patients

HIV Infections
Avexa

Completed

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

HIV Infection

Australia
Avexa

Completed

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

HIV Infections

Australia
Inje University
Bukwang Pharmaceutical

Terminated

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

Chronic Hepatitis B

Korea, Republic of
Tibotec Pharmaceuticals, Ireland

Completed

TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use

HIV Infection
National Institute of Allergy and Infectious Diseases...
Boehringer Ingelheim

Completed

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

HIV Infections

United States
University of California, San Francisco
Universitywide AIDS Research Program

Completed

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

HIV Infections

United States
Yaounde Central Hospital
University of Yaounde; Antenna Technologies

Completed

The Effects of Spirulina Platensis on Insulin Resistance in HIV-infected Patients

HIV/AIDS | Insulin Resistance

Cameroon
French National Agency for Research on AIDS and...
Merck Sharp & Dohme LLC; Janssen-Cilag Tibotec

Completed

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses (ANRS139 TRIO)

HIV Infections

France
St Stephens Aids Trust

Completed

Raltegravir Insulin Sensitivity Study

HIV Infections

United Kingdom
Brigham and Women's Hospital
Merck Sharp & Dohme LLC

Terminated

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

HIV-1 Infection

United States
Göteborg University
Vastra Gotaland Region; Strama - the Swedish strategic programme against antibiotic... and other collaborators

Completed

Clinical Application of PCR-based Diagnosis of Community-onset Viral Respiratory Infections. (luftvagsPCR)

Acute Respiratory Tract Infection

Sweden
Massachusetts General Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Study of Home-Based Resistance and Strength Training in HIV-Infected Women

HIV Infections

United States
Hospital Clinic of Barcelona

Unknown

Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression (RAL-dyn)

HIV Infection

Spain

Search clinical trials for: Viral Resistance

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations